Using automated insulin delivery systems to improve hospital care for diabetes patients
In-hospital use of Automated Insulin Delivery (AID): Current state and future potential
This study is looking at how smart insulin delivery systems can help people with diabetes keep their blood sugar levels stable while they're in the hospital, and it aims to find out if these systems work better than regular insulin treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11249467 on NIH RePORTER |
What this research studies
This research investigates how automated insulin delivery (AID) systems can enhance the management of blood sugar levels in hospitalized patients with diabetes. The approach involves using advanced technology to monitor and adjust insulin delivery in real-time, aiming to reduce complications associated with unstable blood sugar levels. The study will also focus on training and mentorship for the principal investigator to develop expertise in this area. By comparing AID systems to traditional insulin therapy, the research seeks to identify the most effective methods for improving patient outcomes during hospital stays.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized adults with diabetes, particularly those experiencing challenges in managing their blood sugar levels.
Not a fit: Patients who are not hospitalized or those with diabetes that is well-managed without the need for advanced insulin delivery systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better blood sugar control and reduced complications for hospitalized diabetes patients.
How similar studies have performed: Previous studies have shown promising results with continuous glucose monitoring in hospital settings, indicating that AID systems may also be effective.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Hughes, Michael Samuel — Emory University
- Study coordinator: Hughes, Michael Samuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.